期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

基因检测证实胰腺转移性肺腺癌1例报告 被引量：1

原文传递
导出
摘要 近年来，精准医学飞速发展，肿瘤个体化基因检测为疾病的准确诊治提供了可靠依据，复胆大学附属中山医院收治1例经基因检测证实为胰腺转移性肺腺癌的病人。报告如下。 1病历简介 病人女性，77岁。因“右肺癌术后4年，体检发现胰腺肿瘤2个月余”，2015—12—02以“胰腺恶性肿瘤”收入复嚏大学附属中山医院。
作者 韩序 纪元 徐一凡 谢艳红 王单松 匡天涛 施晨晔 楼文晖
机构地区 复旦大学附属中山医院胰腺外科 复旦大学附属中山医院病理科
出处 《中国实用外科杂志》 CSCD 北大核心 2016年第7期771-773,共3页 Chinese Journal of Practical Surgery
基金 国家科技部卫生公益性行业科研专项经费项目(No.201202007) 国家自然科学基金(No.81572294)
关键词 基因检测 胰腺 转移性肺腺癌 DNA突变分析 genetic mutation pancreas lung adenocarcinoma metastasis DNA mutational analysis
分类号 R6 [医药卫生—外科学]
  • 相关文献

参考文献10

  • 1Z'graggen K, Fern 6 ndez-del Castillo C, Rattner DW, et al. Me- lasiases to the pancreas and their surgical extirpation [J ]. Arch Surg, 1998,133(4):413-417; discussion 8-9.
  • 2Hiotis SP, Klimstra I)S, Conion KC, el al. Results after pancreal- ic reseclion for metaslatic lesions [J ]. Ann Surg Oncol,2002,9(7): 675-679.
  • 3Smilh AL, Odronic S1, Springer BS. el al. Solid Iumor melasIases to lhe pancreas diagnosed by FNA: A single-inslitulion experi- ence and review of the literature [ J ]. Cancer Cytopathol,2015.123 (6):347-355.
  • 4Waters L, Si Q, Caraway N, et al. Secondary tumors of the pan- creas diagnosed by endoscopic ultrasound-guided fine-needle aspiration: a 10-year experience [J]. Diagn Cytopathol,2014,42 (9):738-743.
  • 5Bryant KL, Mancias JD, Kimmelrrmn AC, et al. KRAS: feeding pancreatic cancer proliferation [J]. Trends Biochem Sci,2014,39 (2):91-100.
  • 6Oliveira-Cunha M, Hadfield KD, Siriwardena AK, et al. EGFR and KRAS mutatinnal analysis and their correlation to survival in pancreatic and periampullary caner [ J ]. Pane~as,2012,41 (3): 428--434.
  • 7Midha A, Dearden S, MeCormack R. EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII) [J]. Am J Cancer Res, 2015,5(9):2892-2911.
  • 8Shi Y. Li J. Zhang S, et al. Molecular epidemiotogy of EGFR mu- tations in Asian patients with advanced non-small-cell lung cancer of adenocareinoma histology- China's Mainland subset analysis of the PIONEER study [J]. PLoS One,2015,10(ll): e0143515.
  • 9张卉,杨新杰,秦娜,李曦,杨惠夷,农靖颖,吕嘉林,吴羽华,张权,张新勇,王敬慧,周立娟,张树才.肺腺癌EGFR与KRAS基因突变状态分析[J].中国肺癌杂志,2015,18(11):686-690. 被引量：21
  • 10Krasinskas AM, Chiosea SI, Pal T, et al. KRAS mutational analysis and immunohistoehemieal studies can help distinguish pancreatic metastases from primary Iung adenoeare, inomas [J]. Mod Pathol,2014,27(2)'.262-270,.

二级参考文献21

  • 1衣素琴,庄园,朱卫东,等.非小细胞肺癌中KRAS基因突变分析.中华临床医师杂志(电子版),2013,7(20):9111-9115.
  • 2Rosell R, Carcereny E, Gervais R, et al. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small cell lung cancer (EURTAC): amulticenter, open-label, randomized phase 3 trial. Lancet Oncol, 2012, 13(3): 239-246.
  • 3Boram L, Boin L, Gangmin H, et al. KRAS mutation detection in non-small cell lung cancer using a peptide nucletic acid-mediated polymerase chain reaction clamping method and comparative validation with next-generation sequencing. KoreanJ Pathol, 2014, 48(2): 100-107.
  • 4Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N EnglJ Med, 2009, 361(10): 947-957.
  • 5Dahabreh IJ, Linardou H, Siannis F, et al. Somatic EGFR mutation and gene copy gain as predictive biomarkers for response to tyrosine kinase inhibitors in non-small cell lung cancer. Clin Cancer Res, 2010, 16(1): 291-303.
  • 6Zhou C, Wu YL, Chen G, et al. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small- cell lung cancer (OPTIMAL, CTONG-0802): a multicenter, open-label, randomized, phase 3 study. Lancet Oncol, 2011, 12(8): 735-742.
  • 7Jiang M, Zhang C, Wang J, et al. Adenosine A(2A)K modulates cardiovascular function by activating ERK1/2 signal in the rostral ventrolateral medulla of acute myocardial ischemic rats. Life Sci, 2011, 89(5-6): 182-187.
  • 8Koo .IW, Q uiutanilla-Dieck L, Jiang M, et al. Endotoxemia-mediated inflammation potentiates aminoglycoside-induced ototoxicity. Sci Translat Med, 2015, 7(298): 298ra118-298ra118.
  • 9Paez JG, Janne PA, Lee JC, et al. EGFR mutation in lung cancer: correlation with clinical response to gefitinib therapy. Science, 2004, 304(5676): 1497-1500.
  • 10Shi Y, Au JS, Thongprasert S, et al. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small cell lung cancer of adenocarcinoma histology(PIONEER). J Thorac Oncol, 2014, 9(2): 154-162.

共引文献20

同被引文献3

引证文献1

中国实用外科杂志
2016年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部